OBIO — Early Adopter Health Network (EAHN) ### 📋 Eligible Entities - Canadian health technology companies (primary focus on Ontario-based firms) - Private sector health tech innovators and startups - Medical device manufacturers - Software/digital health solution providers - Health IT service companies - Companies with proven technology solutions ready for evaluation and deployment - Firms seeking to validate products in real-world clinical settings ### 💰 Funding Details - Grant Structure: Non-repayable funding for network participation and partnership facilitation - Funding Amount: Varies by project scope; typically covers network membership, evaluation support, and commercialization assistance - Matching Requirements: Cost-sharing arrangements may apply depending on program stream; applicant contribution often expected - Repayability: Non-repayable grant (does not need to be repaid) - Payment Model: Funds disbursed upon milestone completion and partnership development activities ### 🛠️ Approved Expenses - Real-world technology evaluation and validation costs in Ontario health organizations - Clinical trial and pilot project expenses - Health network partnership facilitation and coordination - Market readiness and commercialization activities - Regulatory pathway support and compliance documentation - Integration testing with healthcare systems - Health technology assessment and evidence generation - Stakeholder engagement and adoption planning - Training and implementation support for health organizations ### ⚠️ Conditions & Milestones - Network Integration: Company must actively participate in the Early Adopter Health Network and engage with partner Ontario health organizations - Real-World Evaluation: Technology must undergo testing/validation in actual healthcare settings with willing partner institutions - Timeline: Multi-phase program with defined milestones for evaluation, evidence generation, and adoption readiness - Reporting Requirements: Regular progress reports on pilot outcomes, clinical validation, and adoption metrics - Intellectual Property: Company retains IP rights; OBIO may require acknowledgment of program support - Regulatory Compliance: Technology must meet relevant regulatory standards (Health Canada, provincial requirements) - Adoption Commitment: Demonstrated pathway toward broader health system integration beyond pilot phase - Data Sharing: Agree to share anonymized outcome and performance data to support evidence